|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
6 V1 ~" s6 l9 @1 ?8 m2 ^- z" x, ^2 K* u& H
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
* A# M$ |. H6 j1 B9 H4 S: G% Z/ z2 i# r
头颈肿瘤BU入选ASCO 2025的研究4 L3 ^+ ~' U* A @/ n4 h
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
% k' P2 ^: [6 }4 Y7 `; V肿瘤内科-头颈肿瘤科姜愚团队
- ^2 D6 J4 i0 v3 @5 z# C
1 [1 K5 n# ], X* K+ D# mNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.
0 z5 Y7 u! F8 u) b+ `肿瘤内科-头颈肿瘤科刘磊团队
) @( v! @5 S* X `! B/ t3 B% [- w! K8 ?2 O4 p* Z$ j
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.& V) t. @+ l7 {& \$ M
肿瘤内科-头颈肿瘤科刘磊团队
9 N7 h, D4 b- I8 S# A' N0 _- s' l Z, I; u
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.5 H( B" b" o+ g+ {* C; Q5 f, A6 p
肿瘤内科-头颈肿瘤科刘磊团队- ]- W7 v( ?& N) G
+ D- N/ f$ b* D6 f/ R: ?ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
: r" e# I1 c! q3 a1 n- w# U肿瘤内科-头颈肿瘤科姜愚团队
) s) K( T! u9 r) v! R- Z" s |
|
[复制链接]
发表于 2025-5-2 09:58:22
5 D6 B1 U4 w* T6 g: E4 K; F) l& x